Glutathione supplementation improves macrophage functions in HIV

Area of Science:

• Immunology
• Infectious Diseases
• Biochemistry

Background:

• HIV infection impairs macrophage function and compromises innate immunity.
• Mycobacterium tuberculosis (M. tuberculosis) infection is a significant opportunistic infection in individuals with HIV.
• Glutathione (GSH) is a critical antioxidant and immune regulator depleted in HIV infection.

Purpose of the Study:

• To investigate the efficacy of glutathione-enhancing agents in restoring GSH levels in HIV-infected macrophages.
• To determine the impact of GSH replenishment on intracellular M. tuberculosis growth.
• To elucidate the molecular mechanisms underlying GSH depletion in HIV-associated immune dysfunction.

Main Methods:

• Isolated macrophages from HIV-infected and healthy individuals were treated with N-acetyl cysteine or liposomal glutathione (lGSH).
• Levels of reduced glutathione (rGSH) and intracellular M. tuberculosis growth were quantified.
• Expression of key enzymes involved in GSH synthesis (GCLC, glutathione synthase, glutathione reductase) was assessed.

Main Results:

• N-acetyl cysteine and lGSH treatment replenished rGSH levels in HIV-infected macrophages.
• Replenishment of rGSH correlated with a significant decrease in intracellular M. tuberculosis growth.
• Macrophages from HIV-infected individuals showed reduced levels of GCLC and altered expression of other GSH synthesis enzymes, correlating with increased free radicals and depleted rGSH.

Conclusions:

• HIV infection leads to increased oxidative stress and decreased GCLC, resulting in GSH depletion and impaired innate immune function.
• Restoring GSH levels via enhancing agents offers a novel strategy for controlling M. tuberculosis in HIV patients.
• These findings suggest a potential adjunctive therapy to current HIV treatments, targeting oxidative stress and immune restoration.